You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Colo-rectal Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colo-rectal Cancer Trial in Ravenna (Prehabilitation course)

Recruiting
  • Colo-rectal Cancer
  • Prehabilitation course
  • Ravenna, RA, Italy
    AUSL della Romagna
May 5, 2023

Serum autotaxin Level in Colorectal Cancer

Completed
  • Colo-rectal Cancer
  • Serum autotaxın levels
  • Ankara, Turkey
    Dışkapı Yıldırım Beyazıt training and research hospital
Oct 14, 2023

Spectral CT-scan in Metastatic Colorectal Cancer:Prospective

Recruiting
  • Colo-rectal Cancer
  • CT Images
  • Saint-Étienne, France
    CHU Saint-Etienne
Aug 29, 2023

Gastric/Colorectal Cancers

Not yet recruiting
  • Gastric Cancer
  • Colo-rectal Cancer
  • quantitative Real-time PCR
  • (no location specified)
Nov 27, 2023

Validation of the Global Polypectomy Assessment Tool (GPAT)

Enrolling by invitation
  • Colorectal Adenoma
  • +2 more
    • Ghent, Gent, Belgium
      uz Gent
    May 17, 2023

    Artificial Intelligence in Adenoma Detection for Colonoscopy

    Not yet recruiting
    • Colonic Polyp
    • +2 more
    • GI Genius (GIG)
    • (no location specified)
    May 11, 2023

    Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

    Recruiting
    • Colo-rectal Cancer
    • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
    • Beijing, China/Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medici
    Aug 4, 2023

    Colo-rectal Cancer Trial in Buffalo (Problem solving Skills Training)

    Completed
    Has Results
    • Colo-rectal Cancer
    • Problem solving Skills Training
    • Buffalo, New York
      Roswell Park Cancer Institute
    Sep 9, 2022

    Colo-rectal Cancer Trial (biological, drug, procedure)

    Not yet recruiting
    • Colo-rectal Cancer
    • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    • +8 more
    • (no location specified)
    Aug 28, 2023

    Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

    Completed
    • Gastric Cancer
    • +2 more
    • Ramucirumab Injection
    • Ramucirumab Injection [Cyramza]
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Mar 24, 2023

    Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

    Not yet recruiting
    • Solid Tumor
    • +4 more
    • (no location specified)
    Feb 21, 2023

    Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

    Active, not recruiting
    • Colo-rectal Cancer
    • Metastatic Cancer
    • Besançon, France
    • +2 more
    Jan 24, 2023

    Peritoneum Cancer, Peritoneal Carcinomatosis, Peritoneal Metastases Trial in Odense (PIPAC)

    Recruiting
    • Peritoneum Cancer
    • +3 more
    • Odense, Denmark
      Odense PIPAC Center, Department of Surgery, Odense University Ho
    Oct 5, 2022

    Colorectal Surgery, Colorectal Cancer, Rectal/Anal Trial (COLO BT™, Stoma Creation)

    Not yet recruiting
    • Colorectal Surgery
    • +2 more
    • COLO BT™
    • Stoma Creation
    • (no location specified)
    Apr 12, 2023

    Colon Adenocarcinoma, Liver Metastasis Colon Cancer Trial in Modena (Living donor liver transplant)

    Recruiting
    • Colon Adenocarcinoma
    • Liver Metastasis Colon Cancer
    • Living donor liver transplant
    • Modena, MO, Italy
      Azienda Ospedaliero Universitaria di Modena
    Jan 18, 2022

    Colo-rectal Cancer, Anesthesia Trial in Philadelphia (IV Medications, )

    Recruiting
    • Colo-rectal Cancer
    • Anesthesia
    • IV Medications
    • placebo
    • Philadelphia, Pennsylvania
      Thomas Jefferson
    Jun 3, 2022

    Colo-rectal Cancer, Molecular Pathway Deregulation Trial in Seongnam-si

    Active, not recruiting
    • Colo-rectal Cancer
    • Molecular Pathway Deregulation
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        Seoul National University Bundang Hospital
      May 3, 2022

      Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

      Not yet recruiting
      • Colorectal Cancer
      • +3 more
      • (no location specified)
      Jul 28, 2022

      Colo-rectal Cancer Trial in West Hollywood (Time-Restricted Eating (TRE), Control)

      Recruiting
      • Colo-rectal Cancer
      • Time-Restricted Eating (TRE)
      • Control
      • West Hollywood, California
        Cedars-Sinai Medical Center
      Apr 20, 2022

      Gastrointestinal Tumors Trial (openSide to end colorectal anastomosis ., open end end to end stapler anastomosis)

      Completed
      • Gastrointestinal Neoplasms
      • openSide to end colorectal anastomosis .
      • open end end to end stapler anastomosis
      • (no location specified)
      Sep 13, 2021

      Colo-rectal Cancer, Rectal Prolapse, Colostomy Stoma Trial in San Francisco (Single port robotic colorectal surgical procedure)

      Recruiting
      • Colo-rectal Cancer
      • +3 more
      • Single port robotic colorectal surgical procedure
      • San Francisco, California
        UCSF Medical Center at Mission Bay
      May 20, 2022

      Colo-rectal Cancer, Colonic Tumors Trial in Coimbra (PEG split-dose and simethicone)

      Completed
      • Colo-rectal Cancer
      • Colonic Neoplasms
      • PEG split-dose and simethicone
      • Coimbra, Portugal
        Portuguese Oncology Institute - Coimbra
      Oct 3, 2022

      Colo-rectal Cancer Trial in Sabadell (TRIMODAL PREHABILITATION)

      Recruiting
      • Colo-rectal Cancer
      • TRIMODAL PREHABILITATION
      • Sabadell, Barcelona, Spain
      • +1 more
      Mar 6, 2022

      Colo-rectal Cancer Trial in Haifa (C-Scan System)

      Completed
      • Colo-rectal Cancer
      • C-Scan System
      • Haifa, Israel
        Bnai-Zion Medical Center
      Feb 15, 2022

      Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

      Not yet recruiting
      • Cancer
      • +16 more
      • KVA12123 - Dose Escalation
      • +3 more
      • (no location specified)
      Feb 2, 2023